Acalabrutinib
id:
acalabrutinib-168-11353912
title:
Acalabrutinib
text:
Acalabrutinib, sold under the brand name Calquence, is a medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic Lymphoma (CLL/SLL). It may be used both in relapsed as well as in treatment-naive settings. Common side effects include headaches, feeling tired, low red blood cells, low platelets, and low white blood cells. It is a second generation Bruton's tyrosine kinase inhibitor. Acalabrutinib blocks
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Acalabrutinib
date created:
2015-12-14T21:26:14Z
date modified:
2024-08-31T03:31:15Z
main entity:
{"identifier":"Q23668732","url":"https://www.wikidata.org/entity/Q23668732"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/cd/Acalabrutinib.svg","width":512,"height":217}
fields total:
13
integrity:
16